Amgen | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 64.53B 4.19B 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Amgen USD 53.76B 253M 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Exelixis USD 0 0 2025-04
Genmab DKK 132M 3M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 31.76M 883K 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
J&J USD 38.36B 7.7B 2025-03
Merck USD 33.97B 484M 2025-06
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 24.06B 2.4B 2025-06
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.5B 137M 2025-06
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.2B 211M 2025-06
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Takeda JPY 4.13T 168.47B 2025-06
Teva Pharmaceutical Industries USD 16.76B 533M 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Amgen Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.